<DOC>
	<DOCNO>NCT03041129</DOCNO>
	<brief_summary>The Investigators measure hepatic glucose metabolism upregulated towards de novo lipogenesis ( DNL ) via multiple intrahepatic pathway obese girl PCOS hepatic steatosis ( HS ) , compare PCOS without HS obese control without HS . HS correlate relative post-prandial hyperglycemia . Post-prandial hyperglycemia bad remain unchanged youth treat oral contraceptive well metformin .</brief_summary>
	<brief_title>Post-Prandial Liver Glucose Metabolism Polycystic Ovarian Syndrome ( PCOS ) Understanding Standard Care Medications</brief_title>
	<detailed_description>This cross-sectional study 4 group youth . A 6 hour OGTT ( Oral Glucose Tolerance Test ) oral U-C13 glycerol tracer pair NMR isotopomer analysis serum sample describe flux hepatic pentose phosphate pathway , TCA cycle DNL pathways girl PCOS receive lifestyle , metformin oral contraceptive treatment , obese girl regular menses receive lifestyle therapy . Hepatic steatosis measure MRI .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<criteria>1 . Female 2 . Ages 1221 3 . Sedentary less 2.5 hour moderate ( jogging , swim etc ) exercise week . 4 . BMI equal great 90th percentile age gender 5 . For PCOS group : ( NIH definition ) irregular menstrual cycle least 1.5 year menarche , either clinical evidence hyperandogenism , elevate Testosterone ( norms age/tanner stage ) time screen , document prior initiation therapy OCP metformin group . 6 . For PCOS group : patient untreated currently treat either Metformin 15002000 mg day , oral contraception ( 3035 mcg ethynyl estradiol day ) least 6 month , &gt; 80 % adherence confirm via refill frequency pharmacy . 7 . For nonPCOS group : regular menstrual cycle least 1.5 year menarche , clinical evidence hyperandrogenism . 1 . Use medication know affect insulin sensitivity : oral glucocorticoid within 10 day , atypical antipsychotic , immunosuppressant agent , HIV medication . Nexplanon , DepoProvera Mirena progesterone contraceptive . Dermal patch vaginal ring contraception method . For control : metformin oral contraception . 2 . Currently pregnant breastfeed woman . Development pregnancy study period necessitate withdrawal study . 3 . Severe illness require hospitalization within 60 day 4 . Diabetes , define Hemoglobin A1C &gt; 6.4 % 5 . BMI percentile le 90th percentile age sex . 6 . Weight &gt; 325 lbs &lt; 84 lb . 7 . Anemia , define Hemoglobin &lt; 10 mg/dL 8 . Diagnosed major psychiatric developmental disorder limit informed consent 9 . Implanted metal device compatible MRI 10 . Use blood pressure medication 11 . Known liver disease NAFLD AST ALT &gt; 150 mg/mL</criteria>
	<gender>Female</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>hepatic de novo lipogenesis</keyword>
</DOC>